PuraPharm Corporation Limited (HKG:1498)
Hong Kong · Delayed Price · Currency is HKD 0.3300
-0.0050 (-1.49%)
At close: Feb 13, 2026
PuraPharm Corporation Market Cap
PuraPharm Corporation has a market cap or net worth of 176.57 million as of February 13, 2026. Its market cap has decreased by -8.79% in one year.
Market Cap
176.57M
Enterprise Value
501.13M
Revenue
346.76M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.33
Market Cap Chart
Since July 8, 2015, PuraPharm Corporation's market cap has decreased from 861.75M to 176.57M, a decrease of -79.51%. That is a compound annual growth rate of -13.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 176.57M | -7.04% |
| Dec 31, 2025 | 189.94M | -12.58% |
| Dec 31, 2024 | 217.28M | -38.89% |
| Dec 29, 2023 | 355.55M | -29.69% |
| Dec 30, 2022 | 505.67M | 58.47% |
| Dec 31, 2021 | 319.09M | 19.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fusen Pharmaceutical Company | 554.48M |
| China NT Pharma Group Company | 519.17M |
| Wai Yuen Tong Medicine Holdings | 416.29M |
| Regent Pacific Group | 294.73M |
| Shenzhen Neptunus Interlong Bio-technique Company | 266.80M |
| Tianda Pharmaceuticals | 221.45M |
| Extrawell Pharmaceutical Holdings | 201.45M |
| Joyzyme Group | 193.30M |